<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Al-Sanea MM</submitter><funding>Deanship of Scientific Research at Jouf University</funding><pagination>2162511</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9848286</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>38(1)</volume><pubmed_abstract>A novel series of 12 antipyrine derivatives containing 1,3,4-oxadiazoles (&lt;b>4a-d)&lt;/b>, 1,3,4-thiadiazoles (&lt;b>6a&lt;/b>-&lt;b>d)&lt;/b>, and pyrimidines (&lt;b>8a&lt;/b>-&lt;b>d)&lt;/b>, was preparedand assessed for its potential &lt;i>in vitro&lt;/i> COX-2 inhibitors. Compared to Celecoxib, compounds &lt;b>4b-d&lt;/b> and &lt;b>8d&lt;/b> were the most potent derivatives c with a half-maximal inhibitory concentration range of 53-69 nM. Considering COX-2 selectivity index, compounds &lt;b>4 b&lt;/b> and &lt;b>4c&lt;/b> were chosen among these most potent derivatives for further investigation. The &lt;i>in vivo&lt;/i> ability of compounds &lt;b>4 b&lt;/b> and &lt;b>4c&lt;/b> to counteract carrageenan-induced paw edoema has been assessed and their potential underlying mechanisms have been elucidated and the results have been further validated using molecular docking simulations.</pubmed_abstract><journal>Journal of enzyme inhibition and medicinal chemistry</journal><pubmed_title>Design, synthesis, and biological investigation of oxadiazolyl, thiadiazolyl, and pyrimidinyl linked antipyrine derivatives as potential non-acidic anti-inflammatory agents.</pubmed_title><pmcid>PMC9848286</pmcid><funding_grant_id>DSR2022-RG-0146</funding_grant_id><pubmed_authors>Selim S</pubmed_authors><pubmed_authors>Mohamed AAB</pubmed_authors><pubmed_authors>S Tawfik S</pubmed_authors><pubmed_authors>Othman DIA</pubmed_authors><pubmed_authors>Elshal M</pubmed_authors><pubmed_authors>Mostafa EM</pubmed_authors><pubmed_authors>Brogi S</pubmed_authors><pubmed_authors>Al-Sanea MM</pubmed_authors><pubmed_authors>Parambi DGT</pubmed_authors><pubmed_authors>Ur Rahman H</pubmed_authors><pubmed_authors>M Elbargisy R</pubmed_authors><pubmed_authors>Hamdi A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Design, synthesis, and biological investigation of oxadiazolyl, thiadiazolyl, and pyrimidinyl linked antipyrine derivatives as potential non-acidic anti-inflammatory agents.</name><description>A novel series of 12 antipyrine derivatives containing 1,3,4-oxadiazoles (&lt;b>4a-d)&lt;/b>, 1,3,4-thiadiazoles (&lt;b>6a&lt;/b>-&lt;b>d)&lt;/b>, and pyrimidines (&lt;b>8a&lt;/b>-&lt;b>d)&lt;/b>, was preparedand assessed for its potential &lt;i>in vitro&lt;/i> COX-2 inhibitors. Compared to Celecoxib, compounds &lt;b>4b-d&lt;/b> and &lt;b>8d&lt;/b> were the most potent derivatives c with a half-maximal inhibitory concentration range of 53-69 nM. Considering COX-2 selectivity index, compounds &lt;b>4 b&lt;/b> and &lt;b>4c&lt;/b> were chosen among these most potent derivatives for further investigation. The &lt;i>in vivo&lt;/i> ability of compounds &lt;b>4 b&lt;/b> and &lt;b>4c&lt;/b> to counteract carrageenan-induced paw edoema has been assessed and their potential underlying mechanisms have been elucidated and the results have been further validated using molecular docking simulations.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Dec</publication><modification>2026-05-29T03:04:39.551Z</modification><creation>2025-02-19T02:38:12.018Z</creation></dates><accession>S-EPMC9848286</accession><cross_references><pubmed>36633257</pubmed><doi>10.1080/14756366.2022.2162511</doi></cross_references></HashMap>